FI954050A0 - Lääkekoostumuksia - Google Patents

Lääkekoostumuksia

Info

Publication number
FI954050A0
FI954050A0 FI954050A FI954050A FI954050A0 FI 954050 A0 FI954050 A0 FI 954050A0 FI 954050 A FI954050 A FI 954050A FI 954050 A FI954050 A FI 954050A FI 954050 A0 FI954050 A0 FI 954050A0
Authority
FI
Finland
Prior art keywords
nizatidine
nitro
iii
ethenediamine
contg
Prior art date
Application number
FI954050A
Other languages
English (en)
Swedish (sv)
Other versions
FI954050A (fi
Inventor
Mary Kay Mccauley
Kenneth Philip Moder
Jeffrey Lynn Speakman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI954050A0 publication Critical patent/FI954050A0/fi
Publication of FI954050A publication Critical patent/FI954050A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26—Radicals substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
FI954050A 1994-08-30 1995-08-29 Lääkekoostumuksia FI954050A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/298,486 US5470865A (en) 1994-08-30 1994-08-30 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
FI954050A0 true FI954050A0 (fi) 1995-08-29
FI954050A FI954050A (fi) 1996-03-02

Family

ID=23150736

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954050A FI954050A (fi) 1994-08-30 1995-08-29 Lääkekoostumuksia

Country Status (24)

Country Link
US (1) US5470865A (fi)
EP (1) EP0704214B1 (fi)
JP (1) JPH0892087A (fi)
KR (1) KR960006921A (fi)
CN (1) CN1127635A (fi)
AT (1) ATE192039T1 (fi)
AU (1) AU700488B2 (fi)
BR (1) BR9503832A (fi)
CA (1) CA2157240A1 (fi)
CO (1) CO4410183A1 (fi)
CZ (1) CZ189395A3 (fi)
DE (1) DE69516475T2 (fi)
ES (1) ES2145221T3 (fi)
FI (1) FI954050A (fi)
HU (1) HUT72672A (fi)
IL (1) IL115012A0 (fi)
NO (1) NO952825L (fi)
NZ (1) NZ272833A (fi)
PE (1) PE33696A1 (fi)
PH (1) PH31452A (fi)
PL (1) PL310207A1 (fi)
TR (1) TR199500885A2 (fi)
YU (1) YU57495A (fi)
ZA (1) ZA957281B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010068707A (ko) * 2000-01-07 2001-07-23 최용준 시계줄
JP2001240534A (ja) * 2000-02-29 2001-09-04 Bio Kagaku Kk 液状組成物
KR102178793B1 (ko) * 2019-04-17 2020-11-13 황용석 순금 장식연결구

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
US4760075A (en) * 1980-10-02 1988-07-26 Eli Lilly And Company N-thiazolylmethylthioalkyl-N-alkyl-amidines and related compounds
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine
US4382090A (en) * 1980-10-02 1983-05-03 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds
US4587344A (en) * 1983-02-07 1986-05-06 Eli Lilly And Company Isothiourea synthesis process
PT78063A (en) * 1983-02-07 1984-03-01 Lilly Co Eli Improvements in or relating to the process of synthesis of nizatidine
IL80961A0 (en) * 1985-12-18 1987-03-31 Lilly Co Eli Synthesis of nizatidine
US4777260A (en) * 1985-12-18 1988-10-11 Eli Lilly And Company Synthesis of nizatidine intermediate
US4857344A (en) 1986-12-31 1989-08-15 Del Monte Corporation Method for treating pineapple to inhibit browning
EP0285681B1 (de) * 1987-04-06 1993-03-10 HEUMANN PHARMA GMBH & CO Verfahren zur Herstellung von Nitroethenderivaten
EP0396830B1 (en) * 1989-05-10 1993-10-27 Council of Scientific and Industrial Research An improved process for the preparation of 1-substituted amino-1-substituted thio-2-nitro alkenes
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
CA2055661A1 (en) * 1990-12-21 1992-06-22 Manley A. Paulos Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
US5334725A (en) * 1991-05-21 1994-08-02 Eli Lilly And Company 2-aminomethyl-4-exomethylenethiazoline epoxides
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same

Also Published As

Publication number Publication date
DE69516475T2 (de) 2000-09-28
EP0704214B1 (en) 2000-04-26
NZ272833A (en) 1997-04-24
DE69516475D1 (de) 2000-05-31
PL310207A1 (en) 1996-03-04
KR960006921A (ko) 1996-03-22
TR199500885A2 (tr) 1996-06-21
FI954050A (fi) 1996-03-02
ZA957281B (en) 1997-02-28
PE33696A1 (es) 1996-08-29
ATE192039T1 (de) 2000-05-15
NO952825D0 (no) 1995-07-17
US5470865A (en) 1995-11-28
HUT72672A (en) 1996-05-28
HU9502542D0 (en) 1995-10-30
CN1127635A (zh) 1996-07-31
IL115012A0 (en) 1996-01-31
AU3033495A (en) 1996-03-14
YU57495A (sh) 1999-07-28
AU700488B2 (en) 1999-01-07
EP0704214A1 (en) 1996-04-03
PH31452A (en) 1998-11-03
CO4410183A1 (es) 1997-01-09
JPH0892087A (ja) 1996-04-09
CZ189395A3 (en) 1996-03-13
CA2157240A1 (en) 1996-03-01
BR9503832A (pt) 1996-09-10
ES2145221T3 (es) 2000-07-01
NO952825L (no) 1996-03-01

Similar Documents

Publication Publication Date Title
KR970005014A (ko) 특정 물리적 형태의 n-[4-[5-아미노-1-메틸인돌-3-일-메틸]-3-메톡시벤조일]-2-메틸-벤젠설폰아미드 화합물 및 이의 제조 방법
MX9301536A (es) Agente para regular la condicion grasosa de la piel.
ES2124707T3 (es) Compuestos heterociclicos y su preparacion y utilizacion.
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
PT75210B (en) A method of minimizing water loss from a water-containing topical preparation and a process for preparing said preparation
FR2656610B1 (fr) Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique.
IT7922253A0 (it) Procedimento per fabbricare ammidi di acidi carbossilici alfa, beta-insature, n-sostituite.
FI954050A0 (fi) Lääkekoostumuksia
IT7829682A0 (it) Procedimento per la preparazione di acidi alfa, omega -dicarbossilici.
FR2523965B1 (fr) (benzimidazolyl-1)-1, n-((hydroxy-4 methoxy-3 phenyl)-2 hydroxy-2 ethyl) amino-3 butane et ses sels a activite b-adrenergique, leurs applications therapeutiques, et procede pour les preparer
ATE201882T1 (de) Formulierung von energie
RU96115481A (ru) Способ лечения деформирующего остеоартроза крупных суставов
NO159448C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt n-(2-(((5-dimetylamino)-metyl-2-furanyl)-metyl)-tio)-etyl)-n'-(3,4-metylendioksybenzyl)-2-nitro-1,1-etendiamin.
NZ191699A (en) N-(1-methyl-2-pyrrolidinyl methyl)-2,3-dimethoxy-5-methyl-sulphamoyl benzamide derivatives pharmaceutical compositions
IT1160387B (it) Derivato isossazolico, ad attivita' terapeutica
ES2122387T3 (es) Procedimiento para la preparacion de la forma 1 del clorhidrato de ranitidina.
EP0342565A3 (de) Verwendung des Thiazol-Derivates Tiprotimod zur Herstellung eines Mittels zur Therapie von Virusinfektionen
DK0796256T3 (da) Fremgangsmåde til fremstilling af ranitidin
FI972528A (fi) Menetelmä N-(4-(5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yyli-metyyli)-3-metoksibentsoyyli)-2-metyylibentseenisulfonamidin fysikaalisen muodon valmistamiseksi
DK525980A (da) N-(3-(!-3"-oxapentamethylenaminoaethylidenamino)-2,4,6-trijodbenzoyl)-betaamino-alfa-methylpropiontril og en fremgangsmaade til dets fremstilling
DK157494C (da) Fremgangsmaade til fremstilling af n-(2(((5-((dimethylamino)-methyl)-2-furanyl)methyl)thio)ethyl)-n'(3,4-methylendioxybenzyl)-2-nitro-1,1-ethendiamin
JPS537639A (en) Deamination of alpha-amino acids and their derivatives
ATA177783A (de) Verfahren zur herstellung von n-(2-(((5-(dimethyl-amino)-methyl-2-furanyl)met yl)thio)aethyl)-n' -methyl-2-nitro-1,1-aethendiamin
ES474498A1 (es) Procedimiento para la preparacion de 1-(3-trifluorometilfe- nil)-2-(2-benzoiloxietilamino)-propano.
SE9000658D0 (sv) Mittel zur behandlung der schlaf-apnoe